511509 logo

Vivo Bio Tech Limited Stock Price

BSE:511509 Community·₹537.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

511509 Share Price Performance

₹24.21
-10.80 (-30.85%)
₹24.21
-10.80 (-30.85%)
Price ₹24.21

511509 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with mediocre balance sheet.

5 Risks
1 Reward

Vivo Bio Tech Limited Key Details

₹514.2m

Revenue

₹68.5m

Cost of Revenue

₹445.8m

Gross Profit

₹400.6m

Other Expenses

₹45.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
2.04
86.69%
8.78%
58.4%
View Full Analysis

About 511509

Founded
1987
Employees
174
CEO
Alangudi Sankaranarayanan
WebsiteView website
www.vivobio.com

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory IND preclinical development services; screening and evaluating molecules for various pharmacological properties; and designs and develops of syngeneic / xenograft models for evaluation of anti-cancer agents’ evaluation. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.

Recent 511509 News & Updates

Recent updates

No updates